
Patient Opportunity
Agam is a 12-year-old girl who, until about a year and a half of age, was developing typically and living a peaceful, stable early childhood. Gradually, subtle but concerning changes began to emerge. She became increasingly selective with food, favoring simple carbohydrates and sweets. Over time, she began mouthing non-food items, such as toilet paper. Her eye contact diminished, her ability to communicate declined, and she eventually stopped speaking altogether.
Once a cheerful, expressive child, Agam slowly withdrew into a world of silence. A formal diagnosis soon followed as Agam was identified as being on the autism spectrum. This diagnosis marked a profound turning point in her life and opened the door to exploring deeper clinical insights and potential therapeutic opportunities aimed at supporting her development, communication, and overall well-being.
Approach
As both a pharmacist and chemist, I knew the most effective way to understand what was happening inside Agam’s body was through comprehensive laboratory evaluation. Suspecting nutritional imbalances and metabolic disruption, I ordered an in-depth testing panel, including MosaicDX’s Organic Acids Test (OAT).
Key Findings
The results offered clarity and a roadmap for intervention:
- Low serotonin indicators.
- Fungal overgrowth.
- Elevated FDCA and HMFA.
- Oxidative stress + mitochondrial dysfunction.
These insights guided a targeted, three-step clinical strategy:
- Restore Gut Balance by addressing fungal overgrowth and support microbiome resilience.
- Correct Nutrient Deficiencies by replenishing essential vitamins and minerals foundational for metabolic and neurological health.
- Reduce Oxidative Stress by strengthening mitochondrial activity and improve cellular energy metabolism.
Results
With consistent intervention and ongoing monitoring, significant improvements were observed:
- Agam re-established eye contact.
- Her communication began to return.
- She became more engaged, social, and emotionally expressive.
- Her earlier symptoms were no longer measurable within the autism spectrum.
*The patient name has been changed to protect their privacy.
This material is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Use of this information is at the reader’s discretion and risk.
Insights That Lead to Impact
Now, are you ready to share your success? Let your story inspire others and showcase the incredible impact of your expertise.
Experienced practitioners, submit your case study and inspire others.